Titan Pharmaceuticals Inc
TTNPDelisted Oct 2, 2025- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0000910267
Titan Pharmaceuticals Inc was delisted on Oct 2, 2025; its insiders filed their last Form 4 on Oct 8, 2025; 18 institutions reported holding it in 13F filings for Q3 2025, worth $107.1K in total; no superinvestor held it.
Q1 2022 vs. Q4 2021
How the institutions holding Titan Pharmaceuticals Inc changed between Q4 2021 and Q1 2022.
All holders in Q1 2022All holders in Q4 2021
| Measure | Q4 2021 | Q1 2022 | Change |
|---|---|---|---|
| Holders | 24 | 24 | 0 |
| Shares | 419.1K | 1.30M | +879.4K (+209.8%) |
| Value | $430.0K | $1.24M | +$810.0K (+188.4%) |
New holders (4)
Institutions that held Titan Pharmaceuticals Inc at the end of Q1 2022 but not at the end of Q4 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Armistice Capital, LLC | 863,512 | $826.0K | 0.02% |
| Barclays PLC | 50,050 | $48.0K | 0.00% |
| Joseph P. Lucia & Associates, LLC | 2 | $0 | 0.00% |
| IFP Advisors, Inc | 844 | – | – |
Sold out (4)
Institutions that held Titan Pharmaceuticals Inc at the end of Q4 2021 and filed for Q1 2022 without it.
| Institution | Shares, Q4 2021 | Value, Q4 2021 |
|---|---|---|
| Susquehanna International Group, LLP | 38,930 | $40.0K |
| Virtu Financial LLC | 15,422 | $16.0K |
| Winning Points Advisors, LLC | 11,685 | $15.0K |
| Widmann Financial Services, Inc. | 1 | $0 |